A phase 3 study of revumenib in combination with intensive chemotherapy in patients with newly diagnosed NPM1-mutated acute myeloid leukemia (REVEAL-ND NPM1): Trial in progress

Poster Presentation | Jun 1, 2026

Author

Stein EM, et al.

Congress

American Society of Clinical Oncology Annual Meeting

Chicago, Illinois | May 29 – June 2, 2026